MarketBeat | Real-Time Financial News and Analysis

Open Main Menu Open Sidebar

Repligen Company Profile (NASDAQ:RGEN)

Consensus Ratings for Repligen (NASDAQ:RGEN) (?)
Ratings Breakdown: 1 Buy Rating(s)
Consensus Rating:Buy (Score: 3.00)
Consensus Price Target: $38.00 (7.10% upside)

Analysts' Ratings History for Repligen (NASDAQ:RGEN)
Show:
DateFirmActionRatingPrice TargetActions
4/23/2015Jefferies GroupBoost Price TargetBuy$25.00 -> $38.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
10/17/2014Jefferies GroupReiterated RatingBuy$22.00 -> $25.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
6/26/2014Janney Montgomery ScottInitiated CoverageBuy -> Buy$26.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
6/4/2014Jefferies GroupBoost Price TargetBuy$20.00 -> $22.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
4/15/2014Jefferies GroupInitiated CoverageBuy$17.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
(Data available from 8/4/2013 forward)
            As Featured by CNBC As Featured by The Wall Street Journal As Featured by MarketWatch As Featured by The Boston Globe As Featured by StockTwits As Featured by Seeking Alpha